Shahid Akhtar, Anya Sonia Wernersson, Birgitte Berg, Jonathan Comins, Anne-Marie Barkley Jessen, Bastian Gaardsvig Kjeldsen, Sascha Kopic, Niklas Kahr Rasmussen, Elisabeth Rundell, Gitte Ter-Borch, Thomas Sparre
{"title":"Ease of Use of the Reusable DuraTouch Pen Injector in Individuals with Diabetes with and Without Previous Pen Injector Experience: A Handling Study.","authors":"Shahid Akhtar, Anya Sonia Wernersson, Birgitte Berg, Jonathan Comins, Anne-Marie Barkley Jessen, Bastian Gaardsvig Kjeldsen, Sascha Kopic, Niklas Kahr Rasmussen, Elisabeth Rundell, Gitte Ter-Borch, Thomas Sparre","doi":"10.1177/15209156251363465","DOIUrl":null,"url":null,"abstract":"<p><p>This single-arm handling study assessed whether the reusable DuraTouch® pen injector is easy to use and easy to learn how to use in adults with type 1 diabetes (T1D) or type 2 diabetes (T2D) with or without prior pen injector experience. Following a 15-min training session, participants were instructed to independently administer a simulated DuraTouch injection. Of the 100 included participants (91% with T2D, 9% with T1D), 50% had prior pen injector experience. Pen injector-naive participants required more training time than pen injector-experienced participants (median time, 11 vs. 9 min, respectively). Overall, 85% of participants found DuraTouch very easy or extremely easy to use (using the Diabetes Pen Experience Measure), and 87% found it easy or very easy to learn how to use (using the Injection Device Experience and Acceptability questionnaire). DuraTouch may be a viable pen injector alternative for individuals with diabetes, irrespective of prior pen injector experience.</p>","PeriodicalId":11159,"journal":{"name":"Diabetes technology & therapeutics","volume":" ","pages":""},"PeriodicalIF":6.3000,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes technology & therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15209156251363465","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
This single-arm handling study assessed whether the reusable DuraTouch® pen injector is easy to use and easy to learn how to use in adults with type 1 diabetes (T1D) or type 2 diabetes (T2D) with or without prior pen injector experience. Following a 15-min training session, participants were instructed to independently administer a simulated DuraTouch injection. Of the 100 included participants (91% with T2D, 9% with T1D), 50% had prior pen injector experience. Pen injector-naive participants required more training time than pen injector-experienced participants (median time, 11 vs. 9 min, respectively). Overall, 85% of participants found DuraTouch very easy or extremely easy to use (using the Diabetes Pen Experience Measure), and 87% found it easy or very easy to learn how to use (using the Injection Device Experience and Acceptability questionnaire). DuraTouch may be a viable pen injector alternative for individuals with diabetes, irrespective of prior pen injector experience.
期刊介绍:
Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.